LLY

1,023.95

+0.54%↑

JNJ

199.13

+0.11%↑

ABBV

233.91

-0.32%↓

UNH

309.9

-5.14%↓

AZN

88.55

-1.44%↓

LLY

1,023.95

+0.54%↑

JNJ

199.13

+0.11%↑

ABBV

233.91

-0.32%↓

UNH

309.9

-5.14%↓

AZN

88.55

-1.44%↓

LLY

1,023.95

+0.54%↑

JNJ

199.13

+0.11%↑

ABBV

233.91

-0.32%↓

UNH

309.9

-5.14%↓

AZN

88.55

-1.44%↓

LLY

1,023.95

+0.54%↑

JNJ

199.13

+0.11%↑

ABBV

233.91

-0.32%↓

UNH

309.9

-5.14%↓

AZN

88.55

-1.44%↓

LLY

1,023.95

+0.54%↑

JNJ

199.13

+0.11%↑

ABBV

233.91

-0.32%↓

UNH

309.9

-5.14%↓

AZN

88.55

-1.44%↓

McKesson Corp

Отворен

СекторЗдравеопазване

852.65 0.22

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

840.39

Максимум

857.12

Ключови измерители

By Trading Economics

Приходи

426M

1.2B

Продажби

5.3B

103B

P/E

Средно за сектора

26.881

105.69

EPS

9.86

Дивидентна доходност

0.35

Марж на печалбата

1.173

Служители

43,000

EBITDA

212M

1.5B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+8.77% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.35%

2.37%

Следваща дата на дивидент

2.01.2026 г.

Следваща дата на екс-дивидент

1.12.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

4B

106B

Предишно отваряне

852.43

Предишно затваряне

852.65

Настроения в новините

By Acuity

32%

68%

91 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.11.2025 г., 18:59 ч. UTC

Значими двигатели на пазара

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17.11.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Consolidates Amid Mixed Signals -- Market Talk

17.11.2025 г., 23:34 ч. UTC

Пазарно говорене

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17.11.2025 г., 22:58 ч. UTC

Пазарно говорене

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17.11.2025 г., 22:46 ч. UTC

Пазарно говорене

Risk Assets Set to Have a Strong 2026 -- Market Talk

17.11.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17.11.2025 г., 22:02 ч. UTC

Печалби

Trip.com Group 3Q Rev $2.6B >TCOM

17.11.2025 г., 22:02 ч. UTC

Печалби

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17.11.2025 г., 22:02 ч. UTC

Печалби

Trip.com Group 3Q EPS $4.02 >TCOM

17.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.11.2025 г., 21:40 ч. UTC

Печалби

James Hardie Industries 2Q Adj EPS 26c >JHX

17.11.2025 г., 21:40 ч. UTC

Печалби

James Hardie Industries 2Q Loss/Shr 10c >JHX

17.11.2025 г., 21:39 ч. UTC

Печалби

James Hardie Industries 2Q Sales $1.29B >JHX

17.11.2025 г., 21:38 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17.11.2025 г., 21:38 ч. UTC

Печалби

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17.11.2025 г., 21:10 ч. UTC

Печалби

XP Inc. 3Q EPS BRL2.47 >XP

17.11.2025 г., 21:10 ч. UTC

Печалби

XP Inc. 3Q Rev BRL4.67B >XP

17.11.2025 г., 20:20 ч. UTC

Пазарно говорене

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17.11.2025 г., 20:12 ч. UTC

Пазарно говорене

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17.11.2025 г., 20:12 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.11.2025 г., 20:09 ч. UTC

Пазарно говорене

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17.11.2025 г., 19:29 ч. UTC

Пазарно говорене

Gold Slide Continues to Start Week -- Market Talk

17.11.2025 г., 19:16 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17.11.2025 г., 18:20 ч. UTC

Придобивния, сливания и поглъщания

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17.11.2025 г., 16:45 ч. UTC

Придобивния, сливания и поглъщания

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17.11.2025 г., 16:16 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17.11.2025 г., 16:15 ч. UTC

Печалби

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17.11.2025 г., 15:40 ч. UTC

Придобивния, сливания и поглъщания

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17.11.2025 г., 15:22 ч. UTC

Придобивния, сливания и поглъщания

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17.11.2025 г., 15:19 ч. UTC

Пазарно говорене

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

8.77% нагоре

12-месечна прогноза

Среден 915.92 USD  8.77%

Висок 1,000 USD

Нисък 775 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

15 ratings

13

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

91 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat